PoshanSenseCan walking help stop lower-back pain coming back?
An Australian trial tested walking plus education after recovery from back pain. Why its result supports a gradual supported plan—not a universal step target or an acute-pain cure.
Complementary human studies · Published 2024
Back pain settles, normal life returns, and then a familiar question arrives: what can I do to make it less likely to come back? A complicated exercise routine is not always easy to fit around work or family. Walking sounds more achievable—but does that simplicity have evidence behind it?
Yes, for a specific prevention programme
The promising result is about people who had already recovered, using walking alongside education and professional support. Keeping those details together makes the answer more useful. Dropping them can turn a prevention study into advice it never tested.
“Nonspecific” means the pain was not attributed to a particular diagnosis such as a fracture, infection or cancer. It does not mean the pain was imaginary. It also does not mean that an unfamiliar or ongoing episode should simply be assumed to fit the trial.
What did the result look like?
In WalkBack, the programme group had a lower rate of activity-limiting recurrence over follow-up. The reported hazard ratio was 0.72, with a 95% confidence interval of 0.60–0.85. That is a comparison of recurrence rates over time, not a 28-percentage-point guarantee for an individual.
The estimated median time to first activity-limiting recurrence was 208 days with the programme and 112 days in control. These are group-level estimates. They do not predict the date somebody’s pain will return, and recurrence was not eliminated.
Why this was more than “just go for a walk”
A physiotherapist helped participants develop a progressive plan and provided education and coaching. Starting levels and progression were individualized, with attention to what was realistic and motivating. The trial cannot tell us how much of the benefit came from walking, education, confidence or continuing support.
That is an advantage when thinking about real-life implementation: a routine is more than its exercise name. But it is a limitation if the question is whether an unsupported instruction to walk would produce the same result.
Prevention is a different question from treating today’s pain
Start after recovery
The trial enrolled people who had recovered, not a general acute-pain clinic population.
Build progressively
The programme was tailored and supported, rather than one compulsory step target.
Keep the whole package
Education and physiotherapy coaching accompanied walking.
Allow for uncertainty
Recurrences still happened; adverse events and individual circumstances matter.
Does this give us a perfect daily step target?
No. The study did not establish one step count that prevents back pain worldwide. It also excluded people already walking regularly or meeting higher activity criteria. An already-active runner and a previously inactive adult after recovery are not interchangeable starting points.
Walking needs a setting that works, too. Safe routes, heat, weather, accessibility and available clinical support differ across countries and neighbourhoods. An Australian programme may offer a useful principle to discuss, without its exact delivery or cost translating unchanged to everywhere else.
Accessible does not mean risk-free
The overall number of people reporting an adverse event was similar between groups, but lower-limb events were more frequent in the programme group. That makes it inappropriate to advertise the intervention as harmless or to encourage everybody to jump straight to a demanding target.
The sensible use of this evidence is to discuss a suitable, gradual prevention plan after recovery, particularly if pain has repeatedly returned. New, persistent or concerning symptoms call for appropriate assessment; this explainer cannot identify their cause or choose treatment.
The answer worth keeping
Walking does not have to be dismissed as too ordinary to matter. In a supported prevention programme, it produced a meaningful result. Keep the focus on a routine a person can sustain, with the context and support that made the research programme possible.
Evidence context: Australia’s National Health and Medical Research Council funded the trial. The paper discloses research scholarships and fellowships; other authors reported no competing interests. Most participants were women with multiple previous episodes, and ethnicity was not recorded. Educational article; not clinically reviewed.
Sources & further reading
- Australian WalkBack prevention trial (2024)
- WalkBack full open-access paper
- WalkBack supplementary appendix
Study years differ from this article’s publication date. We reviewed full primary papers and relevant supporting material; access limitations are kept out of efficacy claims. Original illustrations and diagrams; no publisher figures reproduced. Educational writing, not clinical review.
Published 11 October 2026 · Sources checked 11 October 2026. Suggest a correction.